These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 28167342)
1. Cellular transformation of human mammary epithelial cells by SATB2. Yu W; Ma Y; Ochoa AC; Shankar S; Srivastava RK Stem Cell Res; 2017 Mar; 19():139-147. PubMed ID: 28167342 [TBL] [Abstract][Full Text] [Related]
2. Role of SATB2 in human pancreatic cancer: Implications in transformation and a promising biomarker. Yu W; Ma Y; Shankar S; Srivastava RK Oncotarget; 2016 Sep; 7(36):57783-57797. PubMed ID: 27472393 [TBL] [Abstract][Full Text] [Related]
3. Oncogenic Role of SATB2 In Vitro: Regulator of Pluripotency, Self-Renewal, and Epithelial-Mesenchymal Transition in Prostate Cancer. Yu W; Srivastava R; Srivastava S; Ma Y; Shankar S; Srivastava RK Cells; 2024 Jun; 13(11):. PubMed ID: 38891096 [TBL] [Abstract][Full Text] [Related]
4. SATB2/β-catenin/TCF-LEF pathway induces cellular transformation by generating cancer stem cells in colorectal cancer. Yu W; Ma Y; Shankar S; Srivastava RK Sci Rep; 2017 Sep; 7(1):10939. PubMed ID: 28887549 [TBL] [Abstract][Full Text] [Related]
5. Higher expression of SATB2 in hepatocellular carcinoma of African Americans determines more aggressive phenotypes than those of Caucasian Americans. Yu W; Roy SK; Ma Y; LaVeist TA; Shankar S; Srivastava RK J Cell Mol Med; 2019 Dec; 23(12):7999-8009. PubMed ID: 31602781 [TBL] [Abstract][Full Text] [Related]
6. SATB2 targeted by methylated miR-34c-5p suppresses proliferation and metastasis attenuating the epithelial-mesenchymal transition in colorectal cancer. Gu J; Wang G; Liu H; Xiong C Cell Prolif; 2018 Aug; 51(4):e12455. PubMed ID: 29701273 [TBL] [Abstract][Full Text] [Related]
7. Special AT-rich sequence-binding protein 2 (Satb2) synergizes with Bmp9 and is essential for osteo/odontogenic differentiation of mouse incisor mesenchymal stem cells. Chen Q; Zheng L; Zhang Y; Huang X; Wang F; Li S; Yang Z; Liang F; Hu J; Jiang Y; Li Y; Zhou P; Luo W; Zhang H Cell Prolif; 2021 Apr; 54(4):e13016. PubMed ID: 33660290 [TBL] [Abstract][Full Text] [Related]
8. Metformin reduces SATB2-mediated osteosarcoma stem cell-like phenotype and tumor growth via inhibition of N-cadherin/NF-kB signaling. Xu HY; Fang W; Huang ZW; Lu JC; Wang YQ; Tang QL; Song GH; Kang Y; Zhu XJ; Zou CY; Yang HL; Shen JN; Wang J Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4516-4528. PubMed ID: 29131265 [TBL] [Abstract][Full Text] [Related]
9. Special AT-rich sequence-binding protein 2 acts as a negative regulator of stemness in colorectal cancer cells. Li Y; Liu YH; Hu YY; Chen L; Li JM World J Gastroenterol; 2016 Oct; 22(38):8528-8539. PubMed ID: 27784965 [TBL] [Abstract][Full Text] [Related]
10. SATB2 expression increased anchorage-independent growth and cell migration in human bronchial epithelial cells. Wu F; Jordan A; Kluz T; Shen S; Sun H; Cartularo LA; Costa M Toxicol Appl Pharmacol; 2016 Feb; 293():30-6. PubMed ID: 26780400 [TBL] [Abstract][Full Text] [Related]
11. SATB1 and SATB2 play opposing roles in c-Myc expression and progression of colorectal cancer. Mansour MA; Hyodo T; Akter KA; Kokuryo T; Uehara K; Nagino M; Senga T Oncotarget; 2016 Jan; 7(4):4993-5006. PubMed ID: 26701851 [TBL] [Abstract][Full Text] [Related]
12. Chronic alcohol exposure induces hepatocyte damage by inducing oxidative stress, SATB2 and stem cell-like characteristics, and activating lipogenesis. Yu W; Ma Y; Shrivastava SK; Srivastava RK; Shankar S J Cell Mol Med; 2022 Apr; 26(7):2119-2131. PubMed ID: 35152538 [TBL] [Abstract][Full Text] [Related]
13. Isogenic human mammary epithelial cell lines: novel tools for target identification and validation. Comprehensive characterization of an isogenic human mammary epithelial cell model provides evidence for epithelial-mesenchymal transition. Ulbricht U; Sommer A; Beckmann G; Lutzenberger M; Seidel H; Kreft B; Toschi L Breast Cancer Res Treat; 2013 Apr; 138(2):437-56. PubMed ID: 23483306 [TBL] [Abstract][Full Text] [Related]
14. SATB2 suppresses the progression of colorectal cancer cells via inactivation of MEK5/ERK5 signaling. Mansour MA; Hyodo T; Ito S; Kurita K; Kokuryo T; Uehara K; Nagino M; Takahashi M; Hamaguchi M; Senga T FEBS J; 2015 Apr; 282(8):1394-405. PubMed ID: 25662172 [TBL] [Abstract][Full Text] [Related]
15. SATB2 is a novel biomarker and therapeutic target for cancer. Roy SK; Shrivastava A; Srivastav S; Shankar S; Srivastava RK J Cell Mol Med; 2020 Oct; 24(19):11064-11069. PubMed ID: 32885593 [TBL] [Abstract][Full Text] [Related]
16. SATB2-Nanog axis links age-related intrinsic changes of mesenchymal stem cells from craniofacial bone. Zhou P; Wu G; Zhang P; Xu R; Ge J; Fu Y; Zhang Y; Du Y; Ye J; Cheng J; Jiang H Aging (Albany NY); 2016 Sep; 8(9):2006-2011. PubMed ID: 27632702 [TBL] [Abstract][Full Text] [Related]